| __timestamp | Amphastar Pharmaceuticals, Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 210461000 | 23006000000 |
| Thursday, January 1, 2015 | 251519000 | 23923000000 |
| Friday, January 1, 2016 | 255165000 | 27889000000 |
| Sunday, January 1, 2017 | 240175000 | 30186000000 |
| Monday, January 1, 2018 | 294666000 | 30821000000 |
| Tuesday, January 1, 2019 | 322357000 | 33754000000 |
| Wednesday, January 1, 2020 | 349846000 | 34099000000 |
| Friday, January 1, 2021 | 437768000 | 34114000000 |
| Saturday, January 1, 2022 | 498987000 | 29324000000 |
| Sunday, January 1, 2023 | 644395000 | 30328000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, revenue growth is a key indicator of a company's success. Over the past decade, GSK plc and Amphastar Pharmaceuticals, Inc. have shown contrasting revenue trajectories. GSK, a global leader, consistently reported revenues exceeding $30 billion annually, peaking in 2019. However, a slight dip in 2022 saw revenues fall to approximately $29 billion, a 15% decrease from its peak.
Conversely, Amphastar Pharmaceuticals, Inc., a smaller player, has demonstrated impressive growth. From 2014 to 2023, its revenue surged by over 200%, reaching nearly $644 million in 2023. This growth highlights Amphastar's strategic market positioning and innovative product offerings.
These trends underscore the dynamic nature of the pharmaceutical sector, where both established giants and emerging companies can thrive through strategic innovation and market adaptation.
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: GSK plc or Halozyme Therapeutics, Inc.?
Breaking Down Revenue Trends: GSK plc vs BioCryst Pharmaceuticals, Inc.
GSK plc vs Xencor, Inc.: Annual Revenue Growth Compared
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Telix Pharmaceuticals Limited and Amphastar Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
TG Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Merus N.V. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Supernus Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Leads in Yearly Revenue?
Who Generates More Revenue? Mesoblast Limited or Amphastar Pharmaceuticals, Inc.
Annual Revenue Comparison: Amphastar Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.